Literature DB >> 28277249

Glycan-Based Cell Targeting To Modulate Immune Responses.

Timo Johannssen1, Bernd Lepenies2.   

Abstract

Glycosylation is an integral post-translational modification present in more than half of all eukaryotic proteins. It affects key protein functions, including folding, stability, and immunogenicity. Glycoengineering approaches, such as the use of bacterial N-glycosylation systems, or expression systems, including yeasts, insect cells, and mammalian cells, have enabled access to defined and homogenous glycoproteins. Given that glycan structures on proteins can be recognized by host lectin receptors, they may facilitate cell-specific targeting and immune modulation. Myeloid C-type lectin receptors (CLRs) expressed by antigen-presenting cells are attractive targets to shape immune responses. Multivalent glycan display on nanoparticles, liposomes, or dendrimers has successfully enabled CLR targeting. In this review, we discuss novel strategies to access defined glycan structures and highlight CLR targeting approaches for immune modulation.
Copyright © 2016 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  C-type lectin receptors; carbohydrates; dendritic cells; glycoengineering; immune modulation; innate immunity

Mesh:

Substances:

Year:  2016        PMID: 28277249     DOI: 10.1016/j.tibtech.2016.10.002

Source DB:  PubMed          Journal:  Trends Biotechnol        ISSN: 0167-7799            Impact factor:   19.536


  25 in total

Review 1.  Cell membrane-derived nanomaterials for biomedical applications.

Authors:  Ronnie H Fang; Yao Jiang; Jean C Fang; Liangfang Zhang
Journal:  Biomaterials       Date:  2017-03-01       Impact factor: 12.479

Review 2.  C-type lectins: their network and roles in pathogen recognition and immunity.

Authors:  Sabine Mayer; Marie-Kristin Raulf; Bernd Lepenies
Journal:  Histochem Cell Biol       Date:  2016-12-20       Impact factor: 4.304

3.  Impact of Protein Glycosylation on the Design of Viral Vaccines.

Authors:  Kathleen Schön; Bernd Lepenies; Guillaume Goyette-Desjardins
Journal:  Adv Biochem Eng Biotechnol       Date:  2021       Impact factor: 2.635

4.  Glycan-binding profile of DC-like cells.

Authors:  Eugenia M Rapoport; Ekaterina V Moiseeva; Dmitry A Aronov; Sergey V Khaidukov; Galina V Pazynina; Svetlana V Tsygankova; Ivan M Ryzhov; Ivan M Belyanchikov; Tatiana V Tyrtysh; Kenneth C McCullough; Nicolai V Bovin
Journal:  Glycoconj J       Date:  2019-12-13       Impact factor: 2.916

Review 5.  Harnessing molecular recognition for localized drug delivery.

Authors:  Renjie Liu; Ran Zuo; Gregory A Hudalla
Journal:  Adv Drug Deliv Rev       Date:  2021-01-20       Impact factor: 15.470

6.  Quantitative Phosphoproteomic Analysis Reveals Dendritic Cell- Specific STAT Signaling After α2-3-Linked Sialic Acid Ligand Binding.

Authors:  Rui-Jún Eveline Li; Aram de Haas; Ernesto Rodríguez; Hakan Kalay; Anouk Zaal; Connie R Jimenez; Sander R Piersma; Thang V Pham; Alex A Henneman; Richard R de Goeij-de Haas; Sandra J van Vliet; Yvette van Kooyk
Journal:  Front Immunol       Date:  2021-04-22       Impact factor: 7.561

7.  Design, Synthetic Strategies, and Therapeutic Applications of Heterofunctional Glycodendrimers.

Authors:  Leila Mousavifar; René Roy
Journal:  Molecules       Date:  2021-04-22       Impact factor: 4.411

Review 8.  Trefoil Factor Family (TFF) Peptides and Their Links to Inflammation: A Re-evaluation and New Medical Perspectives.

Authors:  Werner Hoffmann
Journal:  Int J Mol Sci       Date:  2021-05-06       Impact factor: 5.923

Review 9.  Potential Application of Combined Therapy with Lectins as a Therapeutic Strategy for the Treatment of Bacterial Infections.

Authors:  João Victor de Oliveira Santos; Ana Lúcia Figueiredo Porto; Isabella Macário Ferro Cavalcanti
Journal:  Antibiotics (Basel)       Date:  2021-05-02

10.  Glycan-Modified Virus-like Particles Evoke T Helper Type 1-like Immune Responses.

Authors:  Mohammad Murshid Alam; Cassie M Jarvis; Robert Hincapie; Craig S McKay; Jiri Schimer; Carlos A Sanhueza; Ke Xu; Roger C Diehl; M G Finn; Laura L Kiessling
Journal:  ACS Nano       Date:  2020-08-17       Impact factor: 15.881

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.